Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12282)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2021 (publication date) through May 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Almeida PH, Matielo CEL, Curvelo LA, Rocco RA, Felga G, Della Guardia B, Boteon YL. Update on the management and treatment of viral hepatitis. World J Gastroenterol 2021; 27(23): 3249-3261 [PMID: 34163109 DOI: 10.3748/wjg.v27.i23.3249] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i23/3249.htm |
| Number | Citing Articles |
| 1 |
Habiba Debbabi, Eya Chakroun, Hajer Hassine, Hela Kchir, Dhouha Cherif, Haythem Yacoub, Nadia Maamouri. Case Report: Acute hepatitis A virus infection presenting with direct antiglobulin test-negative autoimmune hemolytic anemia and α-thalassemia trait. F1000Research 2025; 13: 1224 doi: 10.12688/f1000research.156586.2
|
| 2 |
Shuaibu Hudu, Abdulgafar Jimoh, Kasimu Ibrahim, Ahmed Alshrari. Hepatitis B Therapeutic Vaccine: A Patent Review. Pharmaceuticals 2022; 15(12): 1542 doi: 10.3390/ph15121542
|
| 3 |
Vanessa Zhu, Jürgen Burhenne, Johanna Weiss, Mathias Haag, Ute Hofmann, Matthias Schwab, Stephan Urban, Gerd Mikus, David Czock, Walter E. Haefeli, Antje Blank. Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1128547
|
| 4 |
Moises Martinez-Castillo, Itzel Altamirano-Mendoza, Rafal Zielinski, Waldemar Priebe, Cristina Piña-Barba, Gabriela Gutierrez-Reyes. Collagen matrix scaffolds: Future perspectives for the management of chronic liver diseases. World Journal of Clinical Cases 2023; 11(6): 1224-1235 doi: 10.12998/wjcc.v11.i6.1224
|
| 5 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 6 |
Maheswata Moharana, Subrat Kumar Pattanayak, Fahmida Khan.
Molecular recognition of bio-active triterpenoids from
Swertia chirayita
towards hepatitis Delta antigen: a mechanism through docking, dynamics simulation, Gibbs free energy landscape
. Journal of Biomolecular Structure and Dynamics 2023; 41(24): 14651 doi: 10.1080/07391102.2023.2184173
|
| 7 |
Habiba Debbabi, Eya Chakroun, Hajer Hassine, Hela Kchir, Dhouha Cherif, Haythem Yacoub, Nadia Maamouri. Case Report: Acute hepatitis A virus infection presenting with direct antiglobulin test-negative autoimmune hemolytic anemia and α-thalassemia trait. F1000Research 2024; 13: 1224 doi: 10.12688/f1000research.156586.1
|
| 8 |
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, Sakurako Ito, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Tomohisa Nomura, Manabu Sugita. Current perspectives of viral hepatitis. World Journal of Gastroenterology 2024; 30(18): 2402-2417 doi: 10.3748/wjg.v30.i18.2402
|
| 9 |
Colin Fitzpatrick, Shaira Doherty, Sabina George, Daniel Richardson. Hepatitis E in men who have sex with men: a systematic review. Frontline Gastroenterology 2024; 15(6): 523 doi: 10.1136/flgastro-2024-102797
|
| 10 |
Deepa Augustine, Arya James, K. Preethi. Coexistence of multiple sexually transmitted infections in a human immunodeficiency virus-negative individual. Journal of Skin and Sexually Transmitted Diseases 2022; 4: 127 doi: 10.25259/JSSTD_79_2021
|
| 11 |
Yan Li, Jun Zhou, Tianliang Li. Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.879817
|
| 12 |
Rui Li, Mingwang Shen, Jason J. Ong, Fuqiang Cui, Wenyi Hu, Polin Chan, Zhuoru Zou, Shu Su, Hangting Liu, Lei Zhang, Wai-Kay Seto, William C.W. Wong. Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies. JHEP Reports 2023; 5(10): 100833 doi: 10.1016/j.jhepr.2023.100833
|
| 13 |
Cheng Wang, Cheng Ma, Lihong Gong, Yuqin Guo, Ke Fu, Yafang Zhang, Honglin Zhou, Yunxia Li. Macrophage Polarization and Its Role in Liver Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.803037
|
| 14 |
Tao Sun, Shilin Xiao, Miaomiao Wang, Qian Xie, Liang Zhang, Mingfu Gong, Dong Zhang, Chunyu Zhou. Reactive Oxygen Species Scavenging Nanozymes: Emerging Therapeutics for Acute Liver Injury Alleviation. International Journal of Nanomedicine 2023; : 7901 doi: 10.2147/IJN.S435544
|
| 15 |
Francesco Bruno, Paolo Abondio, Rossella Bruno, Leognano Ceraudo, Ersilia Paparazzo, Luigi Citrigno, Donata Luiselli, Amalia C. Bruni, Giuseppe Passarino, Rosanna Colao, Raffaele Maletta, Alberto Montesanto. Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis. Ageing Research Reviews 2023; 91: 102068 doi: 10.1016/j.arr.2023.102068
|
| 16 |
Wesley D Figg, David L Crawford, Tristen N Taylor, Mayar Al Mohajer. Rare Diagnostic and Clinical Manifestations in an Acute Hepatitis A Infection: A Case Report. Cureus 2022; doi: 10.7759/cureus.29194
|
| 17 |
Meraj Ahmed, Hirdaya Hulas Nag, Pankaj Meena. Clinical approach to patients with thick wall gallbladder. Egyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-01137-3
|
| 18 |
Junhong Lu, Qingwen Deng, Yuehua Chen, Wenbin Liu. Impact of perceived ease of use, organizational support mechanism, and industry competitive pressure on physicians’ use of liver cancer screening technology in medical alliances. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1174334
|
| 19 |
Yu Zhang, Dongsheng Wu, Xiaoling Tian, Bin Chen. From hepatitis B virus infection to acute‐on‐chronic liver failure: The dynamic role of hepatic macrophages. Scandinavian Journal of Immunology 2024; 99(3) doi: 10.1111/sji.13349
|
| 20 |
Chengqian Feng, Jingrong Shi, Yunfu Chen, Sisi Chen, Jianping Cui, Jun Zhang, Xiaowen Zheng, Yaping Wang, Feng Li. A hepatitis B virus-free cccDNA-producing stable cell for antiviral screening. Antiviral Research 2025; 237: 106143 doi: 10.1016/j.antiviral.2025.106143
|
| 21 |
Luigi Santacroce, Lucrezia Bottalico, Ioannis Alexandros Charitos, Francesca Castellaneta, Elona Gaxhja, Skender Topi, Raffaele Palmirotta, Emilio Jirillo. Exploitation of Natural By-Products for the Promotion of Healthy Outcomes in Humans: Special Focus on Antioxidant and Anti-Inflammatory Mechanisms and Modulation of the Gut Microbiota. Antioxidants 2024; 13(7): 796 doi: 10.3390/antiox13070796
|
| 22 |
Lauren A. Newman, Kate Muller, Andrew Rowland. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases. Cellular and Molecular Life Sciences 2022; 79(5) doi: 10.1007/s00018-022-04256-8
|
| 23 |
Laboratory Medicine in Psychiatry and Behavioral Science, Second Edition. 2023; : 641 doi: 10.1176/appi.books.9781615379897.bm06
|
| 24 |
Hind A. Beydoun, Jack Tsai. Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study. Journal of Viral Hepatitis 2024; 31(10): 601 doi: 10.1111/jvh.13981
|
| 25 |
Hikaru Hayashi, Akira Shimizu, Hiroaki Motoyama, Koji Kubota, Tsuyoshi Notake, Hitoshi Masuo, Takahiro Yoshizawa, Kiyotaka Hosoda, Hiroki Sakai, Koya Yasukawa, Yuji Soejima. Safety and oncological benefits of hepatectomy for hepatocellular carcinoma in octogenarians. Asian Journal of Surgery 2023; 46(1): 366 doi: 10.1016/j.asjsur.2022.04.074
|
| 26 |
Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun. Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area. Cancers 2023; 16(1): 150 doi: 10.3390/cancers16010150
|
| 27 |
Abeer Shahzad, Muhammad Bilal Islam, Hira Anas Khan, Zoaib Habib Tharwani, Abdullah Malikzai. Hepatitis B and C in Pakistan: is there hope for a better treatment?. International Journal of Surgery: Global Health 2023; 6(4) doi: 10.1097/GH9.0000000000000216
|
| 28 |
Xiaolei Zhang, Fuyan Tang, Wei Shu, Dongpeng Li, Yuying Liu, Haibin Xiao, Jin Zhou, Ping Li. Small-molecule fluorescent probes for bioactive species in inflammatory disease: arthritis, pneumonia and hepatitis. The Analyst 2023; 148(21): 5303 doi: 10.1039/D3AN01289A
|
| 29 |
Monica Centa, Christelle Thermidor, Maria Isabel Fiel, Konstantina Alexandropoulos. Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis. Clinical Immunology 2023; 256: 109807 doi: 10.1016/j.clim.2023.109807
|
| 30 |
Seung-mo Kim, Yu-ri Lee, Na-kyung Cho, Hong-sik Choi, Kyung-soon Kim. Herbal Medicine for the Treatment of Viral Hepatitis B and C: A Systematic Review of Randomized Controlled Trials. The Journal of Internal Korean Medicine 2021; 42(4): 455 doi: 10.22246/jikm.2021.42.4.455
|
| 31 |
Ka‐Ying Wong, Zhenyu Nie, Man‐Sau Wong, Yang Wang, Juewen Liu. Metal–Drug Coordination Nanoparticles and Hydrogels for Enhanced Delivery. Advanced Materials 2024; 36(26) doi: 10.1002/adma.202404053
|
| 32 |
Aslıhan Demirel, Suleyman Uraz, Zeynep Deniz, Ebubekir Daglilar, Omer Basar, Veysel Tahan, Resat Ozaras. Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?. Journal of Viral Hepatitis 2024; 31(2): 120 doi: 10.1111/jvh.13899
|
| 33 |
Janitha M. Unagolla, Subarna Das, Riley Flanagan, Marin Oehler, Jyothi U. Menon. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives. International Journal of Pharmaceutics 2024; 660: 124381 doi: 10.1016/j.ijpharm.2024.124381
|
| 34 |
Pengyu Luo, Yuna Tang, Nan Chen, Pei Liu, Jing Wang, Yuchen Fan, Huihui Liu, Kai Wang. USP21 is involved in the development of chronic hepatitis B by modulating the immune microenvironment. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02502-w
|
| 35 |
Amol D. Gholap, Pankaj R. Khuspe, Sagar R. Pardeshi, Md Jasim Uddin, Ushasi Das, Navnath T. Hatvate, Satish Rojekar, Prabhanjan Giram, Mohammad Khalid, Yahya E. Choonara, Md. Faiyazuddin. Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon. Advanced Therapeutics 2025; 8(4) doi: 10.1002/adtp.202400169
|
| 36 |
Chenggong Zhu, Zhen Xun, Ruijie Fu, Qunfang Huang, Qishui Ou, Yunlei Xianyu, Can Liu. Nanoparticle-driven biosensors for diagnosis of viral hepatitis. TrAC Trends in Analytical Chemistry 2024; 180: 117985 doi: 10.1016/j.trac.2024.117985
|
| 37 |
Hongmei Wu, Li Liu, Jialin Qu, Chunrui Wang, Xiaofeng Shi, Yu Lei. Chronic active Epstein-Barr virus infection with reinfection of SARS-CoV-2: a case report. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02418-7
|
| 38 |
Sumaiah J. Alarfaj, Abdullah Alzahrani, Anfal Alotaibi, Malak Almutairi, Mashael Hakami, Njood Alhomaid, Noori Alharthi, Ghazwa B. Korayem, Abdullah Alghamdi. The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia. Saudi Pharmaceutical Journal 2022; 30(10): 1448 doi: 10.1016/j.jsps.2022.07.005
|
| 39 |
Clinical diagnosis of viral hepatitis: Current status and future strategies. Diagnostic Microbiology and Infectious Disease 2024; 108(3): 116151 doi: 10.1016/j.diagmicrobio.2023.116151
|
| 40 |
Eliott S. Kim, Evan E. Afshin, Ebby Elahi. The lowly chalazion. Survey of Ophthalmology 2023; 68(4): 784 doi: 10.1016/j.survophthal.2022.11.002
|